VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 132 filers reported holding VBI VACCINES INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3 | -57.1% | 11,750 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $7 | -99.9% | 11,750 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | -11.1% | 11,750 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | -52.6% | 11,750 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $19,000 | -32.1% | 11,750 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $28,000 | -26.3% | 11,750 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $38,000 | +8.6% | 11,750 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $35,000 | -2.8% | 11,750 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $36,000 | +33.3% | 11,750 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $27,000 | +8.0% | 11,750 | +30.6% | 0.00% | -25.0% |
| Q3 2020 | $25,000 | -34.2% | 9,000 | +74900.0% | 0.00% | -33.3% |
| Q2 2020 | $38,000 | +280.0% | 12 | +71.4% | 0.01% | +200.0% |
| Q4 2019 | $10,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |